Cereno Scientific AB logo

CRNO TO1 B - Cereno Scientific AB News Story

SEK0.495 0.0  5.1%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £7.15m
Enterprise Value £6.49m
Revenue £n/a
Position in Universe 1678th / 1866

BRIEF-Cereno Scientific: Start Of Phase II Clinical Trial Approved In In Bulgaria

Tue 19th November, 2019 12:30pm
Nov 19 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC IS ANNOUNCING THAT THE AUTHORITIES IN
BULGARIA
HAVE ISSUED APPROVAL OF START OF PHASE II CLINICAL TRIAL
    * COMPANY INTENDS TO START STUDY AT MID-YEAR 2020 WITH
INTENTION
OF DEMONSTRATING CS1'S PREVENTATIVE EFFECT AGAINST FORMATION OF
BLOOD CLOTS AFTER ORTHOPEDIC SURGERY
    * STUDY WILL BE CONDUCTED IN BOTH BULGARIA AND RUSSIA, AND
COMPANY
HAS PREVIOUSLY BEEN GRANTED TO START STUDY IN RUSSIA

Source text for Eikon:  ID:nWkr7ksw7p 
Further company coverage:  CRNOSb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.